According to Exelixis's latest financial reports the company's total liabilities are $0.67 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $0.67 B | 16.36% |
2022-12-31 | $0.58 B | 43.74% |
2021-12-31 | $0.40 B | 57.08% |
2020-12-31 | $0.25 B | 29.3% |
2019-12-31 | $0.19 B | 48.11% |
2018-12-31 | $0.13 B | -63.59% |
2017-12-31 | $0.37 B | -26.87% |
2016-12-31 | $0.50 B | 7.03% |
2015-12-31 | $0.47 B | 8% |
2014-12-31 | $0.43 B | 0.24% |
2013-12-31 | $0.43 B | 2.92% |
2012-12-31 | $0.42 B | 40.32% |
2011-12-31 | $0.30 B | -48.63% |
2010-12-31 | $0.58 B | 16.17% |
2009-12-31 | $0.50 B | 10.76% |
2008-12-31 | $0.45 B | 40.19% |
2007-12-31 | $0.32 B | 7.15% |
2006-12-31 | $0.30 B | 10.67% |
2005-12-31 | $0.27 B | 14.44% |
2004-12-31 | $0.24 B | 22.6% |
2003-12-31 | $0.19 B | 20.29% |
2002-12-31 | $0.16 B | 49.18% |
2001-12-31 | $0.10 B |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $98.78 B | 14,460.35% | ๐บ๐ธ USA |
Pfizer PFE | $137.21 B | 20,124.63% | ๐บ๐ธ USA |
Amgen AMGN | $90.92 B | 13,301.53% | ๐บ๐ธ USA |
Sanofi SNY | $57.61 B | 8,391.92% | ๐ซ๐ท France |
Merck MRK | $69.04 B | 10,076.21% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $82.48 B | 12,057.65% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $58.82 B | 8,570.61% | ๐ฌ๐ง UK |
Curis CRIS | $57.61 M | -91.51% | ๐บ๐ธ USA |
AVEO Oncology
AVEO | $72.38 M | -89.33% | ๐บ๐ธ USA |